The DOI matches its Crossref record.
Prospective randomized trial comparing the effects of letrazole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation prior to intrauterine insemination (IUI).
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In superovulation, letrozole is associated with few developing follicles and thick endometrium.”
From A new era in ovulation induction (2006) · cites this paper as [54]
In the citing paper
“The use of letrozole for superovulation is associated with a pregnancy rate higher than with the use of clomiphene citrate (CC) (16.7% vs. 5.6%).”
From A new era in ovulation induction (2006) · cites this paper as [54]
In the citing paper
“Moreover, there is a trend for a higher pregnancy rate in the letrozole group than in the CC group (16.7% vs. 5.6%).”
From A new era in ovulation induction (2006) · cites this paper as [54]
In the citing paper
“Compared with CC, letrozole treatment was associated with a lower E 2 level, fewer follicles (1 vs. 2), thicker endometrium (8.6 mm vs. 6.9 mm), and more stromal blood flow.”
From A new era in ovulation induction (2006) · cites this paper as [54]
In the citing paper
“The ideal dose of letrozole for superovulation or ovulation induction is still unknown.”
From A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation (2004) · cites this paper as [9]
In the citing paper
“Two doses regimens have been tested (2.5 mg and 5 mg) with similar response (8,9).”
From A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation (2004) · cites this paper as [9]
Citations
Cited by
Sorted by citations
History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
Santen, R. J., Brodie, H. J., Simpson, E. R., Siiteri, P. K., & Brodie, A. M. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0016 · Cited by 447
Aromatase Inhibitors for Ovulation Induction
Casper, R. F., & Mitwally, M. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1923 · Cited by 272
“for augmentation of ovulation in women with unexplained infertility was carried out at about the same time by Biljan and colleagues ( 74 ) in Montre´al.”
BackgroundA new era in ovulation induction
Holzer, H., Casper, R., & Tulandi, T. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.05.078 · Cited by 194
Self-citationPregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation
Mitwally, M. F., & Casper, R. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03975-4 · Cited by 178
A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation
Al-Fozan, H., Al-Khadouri, M., Tan, S. L., & Tulandi, T. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.04.070 · Cited by 174
Self-citation
Metadata
- Authors
- Sammour, A., Biljan, M. M., Tan, S. L., & Tulandi, T.
- ORCID
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 76
- Issue
- 3
- Pages
- S110
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W1987948244
- Cited by
- 238
- References
- 0
- Citations by year
- 2022: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 30 · 2016: 7 · 2015: 38 · 2014: 31 · 2013: 22 · 2012: 34
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Fertility and Sterility (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- clomiphene citrate, ovulation induction, intrauterine insemination, unexplained infertility, endometrial thickness, folliculogenesis, pregnancy rate, aromatase inhibitors, estradiol, follicle-stimulating hormone, endometrial receptivity, hCG trigger, endometrial receptivity index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
